I

Imcyse SA

55 employees

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

Basic info

Industry

biotechnology research

Sectors

Type 1 Diabetes
Multiple Sclerosis
Biotechnology
Immunotherapeutics
Peptides
Therapeutics
Pharmaceutical
Autoimmune diseases

Date founded

2011

Funding rounds raised

Total raised

$31M

from 12 investors over 12 rounds

I

Imcyse SA raised $26M on February 17, 2021

Investors: SRIW, EPIMEDE, -, -, SFPI-FPIM and KU Leuven

I

Imcyse SA raised $2.2M on June 18, 2019

Investors: Belfius

I

Imcyse SA raised $31M on June 18, 2019

Investors: SRIW, -, LSP (Life Sciences Partners), - and SFPI-FPIM

FAQ